188 related articles for article (PubMed ID: 15096551)
1. Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait.
Sóki J; Fodor E; Hecht DW; Edwards R; Rotimi VO; Kerekes I; Urbán E; Nagy E
J Med Microbiol; 2004 May; 53(Pt 5):413-419. PubMed ID: 15096551
[TBL] [Abstract][Full Text] [Related]
2. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
[TBL] [Abstract][Full Text] [Related]
3. New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strains.
Kato N; Yamazoe K; Han CG; Ohtsubo E
Antimicrob Agents Chemother; 2003 Mar; 47(3):979-85. PubMed ID: 12604530
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
Jeverica S; Sóki J; Premru MM; Nagy E; Papst L
Anaerobe; 2019 Aug; 58():30-34. PubMed ID: 30716401
[TBL] [Abstract][Full Text] [Related]
5. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
[TBL] [Abstract][Full Text] [Related]
7. Identification of CfiA coding genes in Bacteroides fragilis isolates recovered in Argentina. Inconsistencies in CfiA organization and nomenclature.
Litterio MR; Cejas D; Gutkind G; Radice M
Anaerobe; 2017 Dec; 48():257-261. PubMed ID: 29017951
[TBL] [Abstract][Full Text] [Related]
8. A new insertion sequence element containing a cfiA gene in the first imipenem-resistant Bacteroides fragilis strain isolated in Italy.
Cascio GL; Macaccaro L; Centonze AR; Sóki J; Fontana R; Mazzariol A
Int J Antimicrob Agents; 2009 Dec; 34(6):610-1. PubMed ID: 19744834
[No Abstract] [Full Text] [Related]
9. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
10. New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Jeong SH; Lee K; Kim JM; Chong Y
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):343-8. PubMed ID: 20226324
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a carbapenemase-producing clinical isolate of Bacteroides fragilis in Scandinavia: genetic analysis of a unique insertion sequence.
Walsh TR; Onken A; Haldorsen B; Toleman MA; Sundsfjord A
Scand J Infect Dis; 2005; 37(9):676-9. PubMed ID: 16126569
[TBL] [Abstract][Full Text] [Related]
12. Expression of the carbapenemase gene (cfiA) in Bacteroides fragilis.
Edwards R; Read PN
J Antimicrob Chemother; 2000 Dec; 46(6):1009-12. PubMed ID: 11102423
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary.
Sóki J; Urban E; Szöke I; Fodor E; Nagy E
J Med Microbiol; 2000 May; 49(5):427-430. PubMed ID: 10798555
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
Ogane K; Tarumoto N; Kodana M; Onodera A; Imai K; Sakai J; Kawamura T; Takeuchi S; Murakami T; Mitsutake K; Ikebuchi K; Maesaki S; Maeda T
Anaerobe; 2020 Aug; 64():102215. PubMed ID: 32574601
[TBL] [Abstract][Full Text] [Related]
15. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance.
Yamazoe K; Kato N; Kato H; Tanaka K; Katagiri Y; Watanabe K
Antimicrob Agents Chemother; 1999 Nov; 43(11):2808-10. PubMed ID: 10543771
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection and surveillance of cfiA-positive Bacteroides fragilis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Kawamoto Y; Kosai K; Ota K; Uno N; Sakamoto K; Hasegawa H; Izumikawa K; Mukae H; Yanagihara K
Anaerobe; 2021 Dec; 72():102448. PubMed ID: 34537378
[TBL] [Abstract][Full Text] [Related]
17. First Report of Antibiotic Resistance Markers
Sevillano G; Paz Y Miño A; Solís MB; Vaca JP; Zurita-Salinas C; Zurita J
Microb Drug Resist; 2023 Nov; 29(11):533-539. PubMed ID: 37733248
[TBL] [Abstract][Full Text] [Related]
18. Fatal sepsis caused by multidrug-resistant Bacteroides fragilis, harboring a cfiA gene and an upstream insertion sequence element, in Japan.
Nakamura I; Aoki K; Miura Y; Yamaguchi T; Matsumoto T
Anaerobe; 2017 Apr; 44():36-39. PubMed ID: 28108390
[TBL] [Abstract][Full Text] [Related]
19. Determination of the mutant-prevention concentration of imipenem for the two imipenem-susceptible Bacteroides fragilis strains, Q1F2 (cfiA-positive) and ATCC 25282 (cfiA-negative).
Ho PL; Yau CY; Wang Y; Chow KH
Int J Antimicrob Agents; 2018 Feb; 51(2):270-271. PubMed ID: 28782706
[No Abstract] [Full Text] [Related]
20. Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories.
Cordovana M; Kostrzewa M; Sóki J; Witt E; Ambretti S; Pranada AB
Anaerobe; 2018 Dec; 54():246-253. PubMed ID: 29626622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
